Based on the previous findings, compounds (K) and (L) displayed strong BCRP inhibitory activity with IC50 values of 23.4 and 27.6 nM, respectively, when tested against the ABCG2 cancer cell line. This evidence concerns the gene ABCG2 and cancer.